SCHEMBL832503

SCHEMBL832503

CCCCC/N=C/c1ccccn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.53
CYP2C19 P33261 1/20 0.53
NR4A1 P22736 1/20 0.47
MAOA P21397 2/20 0.46
TOP2A P11388 2/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
ATM Q13315 1/20 0.44
G6PC1 P35575 1/20 0.43
USP2 O75604 2/20 0.42
ALDH1A1 P00352 1/20 0.42
PKM P14618 1/20 0.42
MAOB P27338 1/20 0.42
KDM4E B2RXH2 2/20 0.41
LMNA P02545 2/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL832504 1.00 CYP1A2 (0.53) CYP1A2CYP2C19NR4A1MAOATOP2A
SCHEMBL16353929 0.98 CYP1A2 (0.56) CYP1A2CYP2C19NR4A1MAOATOP2A
SCHEMBL10321022 0.98 CYP1A2 (0.56) CYP1A2CYP2C19NR4A1MAOATOP2A
SCHEMBL27112153 0.98 CYP1A2 (0.56) CYP1A2CYP2C19NR4A1MAOATOP2A
SCHEMBL10320909 0.98 CYP1A2 (0.56) CYP1A2CYP2C19NR4A1MAOATOP2A
SCHEMBL16353859 0.98 CYP1A2 (0.56) CYP1A2CYP2C19NR4A1MAOATOP2A
SCHEMBL342149 0.98 CYP1A2 (0.56) CYP1A2CYP2C19NR4A1MAOATOP2A
SCHEMBL16353930 0.98 CYP1A2 (0.56) CYP1A2CYP2C19NR4A1MAOATOP2A
SCHEMBL139351 0.98 CYP1A2 (0.56) CYP1A2CYP2C19NR4A1MAOATOP2A
SCHEMBL10321703 0.98 CYP1A2 (0.56) CYP1A2CYP2C19NR4A1MAOATOP2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11274248-B2 Lanthanoid-containing inorganic material microparticles, wavelength-converting ink, coated article, and determination apparatus SEKISUI CHEMICAL CO., LTD. (JP) 2022-03-15 US disclosed
US-20210054271-A1 LANTHANOID-CONTAINING INORGANIC MATERIAL MICROPARTICLES, WAVELENGTH-CONVERTING INK, COATED ARTICLE, AND DETERMINATION APPARATUS SEKISUI CHEMICAL CO., LTD. (JP) 2021-02-25 US disclosed
EP-3409748-B1 LANTHANOID-CONTAINING INORGANIC MATERIAL MICROPARTICLES, WAVELENGTH-CONVERTING INK, COATED ARTICLE, AND DETERMINATION APPARATUS SEKISUI CHEMICAL CO LTD (JP) 2020-07-15 EP disclosed
EP-3409748-A1 LANTHANOID-CONTAINING INORGANIC MATERIAL MICROPARTICLES, WAVELENGTH-CONVERTING INK, COATED ARTICLE, AND DETERMINATION APPARATUS Sekisui Chemical Co., Ltd. (JP) 2018-12-05 EP disclosed
US-9200104-B2 Polymer WARWICK EFFECT POLYMERS LIMITED (GB) 2015-12-01 US disclosed
US-20150037535-A1 Organic/Inorganic Composite, Manufacturing Method Therefor, Organic/Inorganic Composite Film, Manufacturing Method Therefor, Photonic Crystal, Coating Material, Thermoplastic Composition, Microstructure, Optical Material, Antireflection Member, and Optical Lens ASAHI KASEI CHEMICALS CORPORATION (JP) 2015-02-05 US disclosed
US-8604133-B2 Graft copolymer and process for producing the same TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2013-12-10 US disclosed
US-20130295040-A1 POLYMER WARWICK EFFECT POLYMERS LTD (US) 2013-11-07 US disclosed
US-20120283385-A1 STRUCTURE, TARGET SUBSTANCE-DETECTING ELEMENT AND TARGET SUBSTANCE-DETECTING KIT CANON KABUSHIKI KAISHA (JP) 2012-11-08 US disclosed
WO-2012124693-A1 ORGANIC/INORGANIC COMPOSITE, MANUFACTURING METHOD THEREFOR, ORGANIC/INORGANIC COMPOSITE FILM, MANUFACTURING METHOD THEREFOR, PHOTONIC CRYSTAL, COATING MATERIAL, THERMOPLASTIC COMPOSITION, MICROSTRUCTURE, OPTICAL MATERIAL, ANTIREFLECTION MEMBER, AND OPTICAL LENS 旭化成ケミカルズ株式会社 (JP) 2012-09-20 WO disclosed
US-20110065212-A1 GRAFT POLYMER-CONTAINING SUBSTRATE, METHOD FOR PRODUCING THE SAME, TARGET SUBSTANCE-DETECTING ELEMENT, AND TARGET SUBSTANCE DETECTION KIT CANON KABUSHIKI KAISHA (JP) 2011-03-17 US disclosed
US-20100330704-A1 COMPOSITE PARTICLE, METHOD FOR PRODUCING THE SAME, DISPERSION SOLUTION, MAGNETIC BIOSENSING APPARATUS AND MAGNETIC BIOSENSING METHOD CANON KABUSHIKI KAISHA (JP) 2010-12-30 US disclosed
US-20100292427-A1 STRUCTURAL MEMBER AND METHOD OF PRODUCING THE STRUCTURAL MEMBER CANON KABUSHIKI KAISHA (JP) 2010-11-18 US disclosed
US-20100173223-A1 Graft Copolymer and Process for Producing the Same TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2010-07-08 US disclosed
US-20100036055-A1 Method For Producing Core-Shell Fine Particle and Method for Producing Intermediate Which is Used for Production of the Core-Shell Fine Particle NOF CORPORATION (JP) 2010-02-11 US disclosed
US-20090148346-A1 SUBSTRATE WITH BINDING FUNCTIONAL GROUP CANON KABUSHIKI KAISHA (JP) 2009-06-11 US disclosed
US-20090061533-A1 STRUCTURE, TARGET SUBSTANCE DETECTION ELEMENT AND TARGET SUBSTANCE DETECTION KIT CANON KABUSHIKI KAISHA (JP) 2009-03-05 US disclosed
US-20090000360-A1 Method for Detecting Target Substance and Target-Substance Detection Kit CANON KABUSHIKI KAISHA (JP) 2009-01-01 US disclosed
US-20090005495-A1 STRUCTURE, TARGET SUBSTANCE-DETECTING ELEMENT AND TARGET SUBSTANCE-DETECTING KIT CANON KABUSHIKI KAISHA (JP) 2009-01-01 US disclosed
WO-2000018776-A1 DIMERIC DIIMINE TRANSITION METAL COMPLEX AND CATALYSTS BOREALIS TECHNOLOGY OY (FI) 2000-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130295040-A1 POLYMER PCNA, PARG, COASY CYP1A2 3249/4885CYP2C19 3283/4885NR4A1 3872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.